FLORIDA MMJ COMPLIANCE, SIMPLIFIED
ISO 17025 accredited | DEA registered | PJLA certified | CLIA accredited
ACS Laboratory is compliant with legislation from the Florida Department of Health’s Office of Medical Marijuana Use.
We offer a wide range of tests from potency to pesticides to ensure your product is ready for patient use.
Along with comprehensive and compliant test panels, ACS also offers a la cart R&D testing services.
Select from our range of tests to help develop your premium-quality medical cannabis.
Florida AMENDMENT 2
In 2016, Florida voters passed Amendment 2, known as the Florida Medical Marijuana Legalization Initiative, which legalized cannabis to treat patients with specific medical conditions. Following Amendment 2, the Florida Senate published the Medical Use of Marijuana statute, and its rules are still evolving today.
At ACS Laboratory, we are up to date with Florida’s guidelines and exceed all proposed requirements.
We are FLORIDA State-Compliant.
Florida MMJ Compliance Resources
Florida MMJ RULES IN DEVELOPMENT
According to Florida’s Department of Health (DOH) in statute 381.986, any pesticide used in the production of medical marijuana or low-THC cannabis (hemp) must be registered with the Florida Department of Agriculture and Consumer Services or the United States Environmental Protection Agency (EPA). These pesticides must be classified as minimum risk, and the ingredients in the pesticide must be exempt from tolerance requirements. Florida law also requires that medical marijuana be tested for residual pesticides.
Aside from pesticides, the DOH’s proposed lab certification and testing standards rules state that medical cannabis cannot contain any level of microbes, mycotoxins, agricultural agents, residual solvents, heavy metals, or filth and foreign materials found in an amount that exceeds any of the department’s accepted limitations. At ACS, we analyze medical cannabis in accordance with these rules.
Full Panel Contaminant Tests Include:
CANNABINOID PROFILE TESTING
According to the proposed rules, all medical cannabis must also be tested to determine its cannabinoid profile before it can be sold to patients. The rules specify the following cannabinoids: d9-THC, d8-THC, THCA, THCV, CBD, CBDA, CBDV, CBG, CBGA, CBN and CBC.
What About Federal Compliance?
Cannabis remains a Schedule 1 drug, according to the Controlled Substances Act.
Until the federal ban is lifted, there are currently no federal rules related to medical cannabis testing.
At ACS Laboratory, we conduct R+D testing, intended for manufacturers and cultivators who want to utilize the results to improve the process of creating high-THC products. R&D tests are conducted using the same protocols as compliance tests.
The only difference is that you may select an R+D test individually based on your category of interest, and R+D test results are not reported. On the other hand, you may choose compliance testing if you want a full panel to guarantee that your product is free of all contaminants below.
**Disclaimer: This content is current as of 06/09/2020. It is meant to be a guiding resource and should not be used to replace legal counsel. Please speak to a lawyer to confirm all questions related to compliance testing.